These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 356180)

  • 21. Distribution of beta-lactamases A and B in some groups of Yersinia enterocolitica and their role in resistance.
    Cornelis G
    J Gen Microbiol; 1975 Dec; 91(2):391-402. PubMed ID: 1043915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.
    Kojo H; Nishida M; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1979 Nov; 16(5):549-53. PubMed ID: 316684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New molecules from old classes: revisiting the development of beta-lactams.
    Page MG; Heim J
    IDrugs; 2009 Sep; 12(9):561-5. PubMed ID: 19697275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
    Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-lactamases.
    Richmond MH
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):135-6. PubMed ID: 311757
    [No Abstract]   [Full Text] [Related]  

  • 27. R-factor mediated beta-lactamase production by Haemophilus influenzae.
    Sykes RB; Matthew M; O'Callaghan CH
    J Med Microbiol; 1975 Aug; 8(3):437-41. PubMed ID: 1080810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-quantification of a microbiological method using beta-lactamases in detecting the hydrolysis of beta-lactam antibiotics.
    Labia R; Guionie M
    Ann Microbiol (Paris); 1981; 132B(2):257-65. PubMed ID: 7034613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in Greece.
    Neonakis IK; Baritaki S; Georgiladakis A; Spandidos DA
    Roum Arch Microbiol Immunol; 2008; 67(1-2):10-3. PubMed ID: 19284160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multifactorial analysis of the phenotypes for beta-lactams of 1044 Escherichia coli strains].
    Chardon H; Fosse T; Labia R; Nicolas MH; Poyart-Salmeron C; Sirot J; Sirot D; Veron M
    Pathol Biol (Paris); 1993 Apr; 41(4):337-42. PubMed ID: 8233632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of some cephalosporins and ampicillin on some beta-lactamase- and non-beta-lactamase-producing strains of gram-negative bacteria.
    Russell AD
    Microbios; 1974 Apr; 10(37):29-38. PubMed ID: 4604409
    [No Abstract]   [Full Text] [Related]  

  • 32. Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases.
    Greenwood D; Pearson NJ; O'Grady F
    J Antimicrob Chemother; 1976 Dec; 2(4):337-43. PubMed ID: 802124
    [No Abstract]   [Full Text] [Related]  

  • 33. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.
    Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
    Reading C; Cole M
    Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.
    Richmond MH; Wotton S
    Antimicrob Agents Chemother; 1976 Aug; 10(2):219-22. PubMed ID: 791093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The -lactamases of gram-negative bacteria and their transfer by R-factors.
    Jack GW; Sykes RB; Richmond MH
    Pathol Microbiol (Basel); 1970; 36(5):289-98. PubMed ID: 4998257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.